臨床試験における人工知能（AI）の世界市場レポート 2025年

臨床試験における人工知能（AI）市場規模は、今後数年間で飛躍的な成長が見込まれます。2029年にはCAGR39.2％で380億3,000万米ドルに成長します。予測期間の成長は、個別化医療の重視、リアルタイム・モニタリング・ソリューション、遠隔試験実施、リスク予測と軽減、データソース統合の拡大に起因しています。予測期間の主な動向には、適応型試験デザイン、データ分析における自然言語処理（NLP）、AI主導の患者募集、データセキュリティのためのブロックチェーン統合、患者転帰の予測分析などが含まれます。

臨床試験における人工知能（AI）市場の成長が予想される背景には、臨床試験コストの抑制が急務となっていることがあります。臨床試験は、個人に対する医学的、外科的、または行動学的介入を評価するもので、研究と患者のケアに関連する費用が発生します。医薬品開発やその他の臨床試験プロセスには本質的にコストがかかるため、より効率的な創薬、より設計された安全な臨床試験の実施、患者の転帰の改善など、すべてのコストを削減するために人工知能が応用されるようになりました。例えば、Genetic Engineering and Biotechnology Newsが2023年2月に発表したレポートでは、世界のバイオ医薬品企業上位20社の新薬開発コストが15%増加し、2022年の2億9,800万米ドルから2023年には約23億米ドルに上昇することが強調されています。この費用には、臨床試験を含む医薬品開発中に発生する費用が含まれます。さらに、全米経済研究所の 2023 年 1 月のレポートでは、今後 5 年以内に AI が導入されることで、医療費の5～10%、つまり年間約 2,000億～ 3,600億米ドル相当の大幅なコスト削減が実現すると予測されています。したがって、臨床試験コストの抑制が急務となっていることが、人工知能臨床試験市場を牽引すると予想されます。

臨床試験における人工知能（AI）市場の成長を促進すると予想される要因は、研究開発活動の量の増加です。研究開発（R&D）活動には、新しい製品、プロセス、知識を生み出すために組織や個人が行う調査、実験、革新の体系的なプロセスが含まれます。人工知能（AI）は、多様なデータセットの分析、適応的な試験デザインの実施、管理プロセスの合理化など、臨床試験の文脈における研究開発活動の様々な側面に大きく貢献しています。例えば、Xtalksの2023年5月のレポートでは、医薬品の研究開発パイプラインが2021年の18,582品目から2022年には20,109品目以上に増加すると指摘しています。さらに、登録された臨床試験の数は2023年に452,604件に急増し、2021年の365,000件以上から大幅に増加しました。その結果、研究開発活動の活発化が人工知能臨床試験市場の成長を促進すると予想されます。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場：金利、インフレ、地政学、コロナ禍、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界の臨床試験における人工知能（AI） PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の臨床試験における人工知能（AI）市場：成長率分析
• 世界の臨床試験における人工知能（AI）市場の実績：規模と成長, 2019-2024
• 世界の臨床試験における人工知能（AI）市場の予測：規模と成長, 2024-2029, 2034F
• 世界の臨床試験における人工知能（AI）総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の臨床試験における人工知能（AI）市場：提供別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ソフトウェア
• サービス
• 世界の臨床試験における人工知能（AI）市場：プロセス別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 試験設計
• 患者の選択
• サイトの選択
• 患者モニタリング
• 世界の臨床試験における人工知能（AI）市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 腫瘍学
• 神経疾患および症状
• 心血管疾患
• 代謝疾患
• 感染症
• 免疫疾患
• その他の用途
• 世界の臨床試験における人工知能（AI）市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 製薬およびバイオテクノロジー会社
• 契約調査機関
• その他のエンドユーザー
• 世界の臨床試験における人工知能（AI）市場、タイプ別サブセグメンテーション：ソフトウェア、実績と予測, 2019-2024, 2024-2029F, 2034F
• AI駆動型分析プラットフォーム
• データ管理ツール
• 患者募集ソリューション
• 予測モデリングソフトウェア
• 世界の臨床試験における人工知能（AI）市場、タイプ別サブセグメンテーション：サービス、実績と予測, 2019-2024, 2024-2029F, 2034F
• コンサルティングサービス
• データ注釈およびラベル付けサービス
• カスタムAIモデル開発
• 実装および統合サービス

第7章 地域別・国別分析

• 世界の臨床試験における人工知能（AI）市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の臨床試験における人工知能（AI）市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 臨床試験における人工知能（AI）市場：競合情勢
• 臨床試験における人工知能（AI）市場：企業プロファイル
  • Medable Inc. Overview, Products and Services, Strategy and Financial Analysis
  • PathAI inc. Overview, Products and Services, Strategy and Financial Analysis
  • Saama Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • TriNetX LLC Overview, Products and Services, Strategy and Financial Analysis
  • SymphonyAI Summit Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Aktana
• Nference Inc.
• Insilico Medicine Inc.
• Vineti Inc.
• Innoplexus AG
• Healx
• AiCure Inc.
• MEDIAN Technologies SA
• Owkin Inc.
• Science 37
• Ardigen SA
• Cyft Inc.
• Unlearn.AI Inc.
• Mendel AI
• Deep Lens Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 臨床試験における人工知能（AI）市場2029：新たな機会を提供する国
• 臨床試験における人工知能（AI）市場2029：新たな機会を提供するセグメント
• 臨床試験における人工知能（AI）市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

The application of artificial intelligence in clinical trials involves utilizing AI to enhance the efficiency and adequacy of trial designs. AI is employed in clinical trials to optimize trial processes by making predictions regarding patient behavior and drug efficacy.

The primary offerings of AI in clinical trials encompass both software and services. Software solutions involve the development or configuration of customized solutions to address specific challenges. Artificial intelligence software is utilized to facilitate quicker and more accurate hypothesis generation and to gain insights into disease progression. These applications extend to various stages of the clinical trial process, including trial design, patient selection, site selection, and patient monitoring across a range of medical fields such as oncology, neurological diseases, cardiovascular diseases, metabolic diseases, infectious diseases, and immunology diseases. The beneficiaries of AI in clinical trials include pharmaceutical and biotechnology companies, contract research organizations, and other relevant stakeholders.

The artificial intelligence (AI) in clinical trials research report is one of a series of new reports from The Business Research Company that provides artificial intelligence (AI) in clinical trials market statistics, including the artificial intelligence (AI) in clinical trials industry's global market size, regional shares, competitors with an artificial intelligence (AI) in clinical trials market share, detailed artificial intelligence (AI) in clinical trials market segments, market trends and opportunities, and any further data you may need to thrive in the artificial intelligence (AI) in clinical trials industry. This artificial intelligence (AI) in clinical trials market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The artificial intelligence (AI) in clinical trials market size has grown exponentially in recent years. It will grow from $7.19 billion in 2024 to $10.14 billion in 2025 at a compound annual growth rate (CAGR) of 41.1%. The growth in the historic period can be attributed to increasing data complexity, rising costs and time constraints, regulatory demands, early ai applications, patient-centric approaches

The artificial intelligence (AI) in clinical trials market size is expected to see exponential growth in the next few years. It will grow to $38.03 billion in 2029 at a compound annual growth rate (CAGR) of 39.2%. The growth in the forecast period can be attributed to personalized medicine emphasis, real-time monitoring solutions, remote trial execution, risk prediction and mitigation, expanded data sources integration. Major trends in the forecast period include adaptive trial design, natural language processing (NLP) in data analysis, ai-driven patient recruitment, blockchain integration for data security, predictive analytics for patient outcomes.

The anticipated growth in the artificial intelligence clinical trial market is driven by the growing imperative to control clinical trial costs. Clinical trials, which evaluate medical, surgical, or behavioral interventions in individuals, incur expenses related to research and patient care. The inherently costly nature of drug development and other clinical trial processes has led to the application of artificial intelligence for more efficient drug discovery, the creation of better-designed and safer clinical trials, and improved patient outcomes-all at reduced costs. For instance, a February 2023 report from Genetic Engineering and Biotechnology News highlighted a 15% increase in the cost of developing a new drug among the top 20 global biopharma companies, rising from $298 million in 2022 to approximately $2.3 billion in 2023. This cost encompasses expenses incurred during drug development, including clinical trials. Additionally, a January 2023 report from the National Bureau of Economic Research projected significant cost savings in healthcare-ranging from 5 to 10% of healthcare spending, translating to approximately $200 billion to $360 billion in annual savings-attributed to the adoption of AI within the next five years. Hence, the imperative to control clinical trial costs is expected to drive the artificial intelligence clinical trial market.

The factor expected to drive the growth of artificial intelligence in the clinical trial market is the increasing volume of research and development activities. Research and Development (R&D) activities involve a systematic process of investigation, experimentation, and innovation conducted by organizations or individuals to create new products, processes, or knowledge. Artificial Intelligence (AI) significantly contributes to various facets of R&D activities in the context of clinical trials, including the analysis of diverse datasets, implementation of adaptive trial designs, and streamlining administrative processes. For instance, a May 2023 report from Xtalks noted an increase in the R&D pipeline for drugs from 18,582 in 2021 to over 20,109 drugs in 2022. Furthermore, the global count of registered clinical trials surged to 452,604 in 2023, marking a substantial rise from the reported figure of over 365,000 trials in 2021. Consequently, the escalating number of research and development activities is expected to propel the artificial intelligence clinical trial market's growth.

An emerging trend in the artificial intelligence in clinical trial market is the introduction of innovative product offerings. Leading companies in this market have unveiled novel products to maintain their competitive standing. For example, in January 2023, Elligo Health Research Inc., a healthcare-enabling research organization based in the US, rolled out DataAI Connect. This groundbreaking data and technology platform facilitate swift, data-driven clinical research by seamlessly collecting, managing, evaluating, and sharing real-world patient data. unlike as mere supplementary technology, this adaptable and sustainable platform presents a comprehensive strategy to overcome clinical trial challenges. It features an all-in-one solution for retrieving and assessing medical records, utilizing cutting-edge technologies such as Natural Language Processing (NLP), Machine Learning (ML), and clinical expertise to transform data into actionable insights and individual patient progress information.

Major players in the artificial intelligence in clinical trials market are directing their efforts toward developing innovative technologies such as AI feasibility and recruitment platforms. These platforms leverage artificial intelligence (AI) to evaluate the viability and potential success of clinical trials, while also aiding in the efficient recruitment of suitable participants. For instance, in June 2023, a US-based research provider company unveiled 'ObjectiveScreen,' an AI-powered feasibility and recruitment platform that enhances clinical trial performance and outcomes by improving patient identification, prequalification, and retention processes. ObjectiveScreen establishes direct connectivity between clinical trial sites and the electronic health records (EHRs) of patients, promoting patient engagement through simplified and streamlined appointment scheduling and communication processes.

In January 2023, Paradigm Health Inc., a US-based healthcare technology company, acquired Deep Lens Inc. The acquisition is geared towards providing Paradigm with Deep Lens's platform, which ensures equal access to trials for all patients while enhancing trial efficiency and reducing barriers to participation for healthcare providers. Deep Lens Inc., based in the US, is a provider of an AI-driven cloud platform for clinical research.

Major companies operating in the artificial intelligence (AI) in clinical trials market include Medable Inc., PathAI inc., Saama Technologies Inc., TriNetX LLC, SymphonyAI Summit Inc., Aktana, Nference Inc., Insilico Medicine Inc., Vineti Inc., Innoplexus AG, Healx, AiCure Inc., MEDIAN Technologies SA, Owkin Inc., Science 37, Ardigen SA, Cyft Inc., Unlearn.AI Inc., Mendel AI, Deep Lens Inc., Antidote Technologies Inc., Arterys Inc., Euretos BV, Halo Health Systems Inc., Trials.Ai Inc., Transparency Life Sciences, BioAge Labs Inc., Wave Life Sciences Ltd., BioSymetrics Inc.

North America was the largest region in the artificial intelligence (AI) in clinical trials market in 2024. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence (ai) in clinical trials market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the artificial intelligence (ai) in clinical trials market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The artificial intelligence (AI) in clinical trials market consists of revenues earned by entities by providing artificial intelligence in clinical trials services that include data security and compliance services and consulting and implementation services. The market value includes the value of related goods sold by the service provider or included within the service offering. The artificial intelligence (AI) in the clinical trials market also includes sales of clinical trial matching software, patient recruitment software and medical image analysis software. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Artificial Intelligence (AI) In Clinical Trials Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on artificial intelligence (ai) in clinical trials market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for artificial intelligence (ai) in clinical trials ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The artificial intelligence (ai) in clinical trials market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Offering: Software; Services
• 2) By Process: Trial Design; Patient Selection; Site Selection; Patient Monitoring
• 3) By Application: Oncology; Neurological Disease And Condition; Cardiovascular Disease; Metabolic Disease; Infectious Disease; Immunology Disease; Other Applications
• 4) By End-User: Pharmaceutical And Biotechnology Company; Contract Research Organizations; Other End-Users
• Subsegments:
• 1) By Software: AI-driven Analytics Platforms; Data Management Tools; Patient Recruitment Solutions; Predictive Modeling Software
• 2) By Services: Consulting Services; Data Annotation And Labeling Services; Custom AI Model Development; Implementation And Integration Services
• Companies Mentioned: Medable Inc.; PathAI inc.; Saama Technologies Inc.; TriNetX LLC; SymphonyAI Summit Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Artificial Intelligence (AI) In Clinical Trials Market Characteristics

3. Artificial Intelligence (AI) In Clinical Trials Market Trends And Strategies

4. Artificial Intelligence (AI) In Clinical Trials Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Artificial Intelligence (AI) In Clinical Trials Growth Analysis And Strategic Analysis Framework

• 5.1. Global Artificial Intelligence (AI) In Clinical Trials PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Artificial Intelligence (AI) In Clinical Trials Market Growth Rate Analysis
• 5.4. Global Artificial Intelligence (AI) In Clinical Trials Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Artificial Intelligence (AI) In Clinical Trials Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Artificial Intelligence (AI) In Clinical Trials Total Addressable Market (TAM)

6. Artificial Intelligence (AI) In Clinical Trials Market Segmentation

• 6.1. Global Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Software
• Services
• 6.2. Global Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Trial Design
• Patient Selection
• Site Selection
• Patient Monitoring
• 6.3. Global Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Oncology
• Neurological Disease And Condition
• Cardiovascular Disease
• Metabolic Disease
• Infectious Disease
• Immunology Disease
• Other Applications
• 6.4. Global Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmaceutical And Biotechnology Company
• Contract Research Organizations
• Other End-Users
• 6.5. Global Artificial Intelligence (AI) In Clinical Trials Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• AI-driven Analytics Platforms
• Data Management Tools
• Patient Recruitment Solutions
• Predictive Modeling Software
• 6.6. Global Artificial Intelligence (AI) In Clinical Trials Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Consulting Services
• Data Annotation And Labeling Services
• Custom AI Model Development
• Implementation And Integration Services

7. Artificial Intelligence (AI) In Clinical Trials Market Regional And Country Analysis

• 7.1. Global Artificial Intelligence (AI) In Clinical Trials Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Artificial Intelligence (AI) In Clinical Trials Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Artificial Intelligence (AI) In Clinical Trials Market

• 8.1. Asia-Pacific Artificial Intelligence (AI) In Clinical Trials Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Artificial Intelligence (AI) In Clinical Trials Market

• 9.1. China Artificial Intelligence (AI) In Clinical Trials Market Overview
• 9.2. China Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Artificial Intelligence (AI) In Clinical Trials Market

• 10.1. India Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Artificial Intelligence (AI) In Clinical Trials Market

• 11.1. Japan Artificial Intelligence (AI) In Clinical Trials Market Overview
• 11.2. Japan Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Artificial Intelligence (AI) In Clinical Trials Market

• 12.1. Australia Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Artificial Intelligence (AI) In Clinical Trials Market

• 13.1. Indonesia Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Artificial Intelligence (AI) In Clinical Trials Market

• 14.1. South Korea Artificial Intelligence (AI) In Clinical Trials Market Overview
• 14.2. South Korea Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Artificial Intelligence (AI) In Clinical Trials Market

• 15.1. Western Europe Artificial Intelligence (AI) In Clinical Trials Market Overview
• 15.2. Western Europe Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Artificial Intelligence (AI) In Clinical Trials Market

• 16.1. UK Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Artificial Intelligence (AI) In Clinical Trials Market

• 17.1. Germany Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Artificial Intelligence (AI) In Clinical Trials Market

• 18.1. France Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Artificial Intelligence (AI) In Clinical Trials Market

• 19.1. Italy Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Artificial Intelligence (AI) In Clinical Trials Market

• 20.1. Spain Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Artificial Intelligence (AI) In Clinical Trials Market

• 21.1. Eastern Europe Artificial Intelligence (AI) In Clinical Trials Market Overview
• 21.2. Eastern Europe Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Artificial Intelligence (AI) In Clinical Trials Market

• 22.1. Russia Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Artificial Intelligence (AI) In Clinical Trials Market

• 23.1. North America Artificial Intelligence (AI) In Clinical Trials Market Overview
• 23.2. North America Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Artificial Intelligence (AI) In Clinical Trials Market

• 24.1. USA Artificial Intelligence (AI) In Clinical Trials Market Overview
• 24.2. USA Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Artificial Intelligence (AI) In Clinical Trials Market

• 25.1. Canada Artificial Intelligence (AI) In Clinical Trials Market Overview
• 25.2. Canada Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Artificial Intelligence (AI) In Clinical Trials Market

• 26.1. South America Artificial Intelligence (AI) In Clinical Trials Market Overview
• 26.2. South America Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Artificial Intelligence (AI) In Clinical Trials Market

• 27.1. Brazil Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Artificial Intelligence (AI) In Clinical Trials Market

• 28.1. Middle East Artificial Intelligence (AI) In Clinical Trials Market Overview
• 28.2. Middle East Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Artificial Intelligence (AI) In Clinical Trials Market

• 29.1. Africa Artificial Intelligence (AI) In Clinical Trials Market Overview
• 29.2. Africa Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Offering, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Process, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Artificial Intelligence (AI) In Clinical Trials Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Artificial Intelligence (AI) In Clinical Trials Market Competitive Landscape And Company Profiles

• 30.1. Artificial Intelligence (AI) In Clinical Trials Market Competitive Landscape
• 30.2. Artificial Intelligence (AI) In Clinical Trials Market Company Profiles
  • 30.2.1. Medable Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. PathAI inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Saama Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. TriNetX LLC Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. SymphonyAI Summit Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Artificial Intelligence (AI) In Clinical Trials Market Other Major And Innovative Companies

• 31.1. Aktana
• 31.2. Nference Inc.
• 31.3. Insilico Medicine Inc.
• 31.4. Vineti Inc.
• 31.5. Innoplexus AG
• 31.6. Healx
• 31.7. AiCure Inc.
• 31.8. MEDIAN Technologies SA
• 31.9. Owkin Inc.
• 31.10. Science 37
• 31.11. Ardigen SA
• 31.12. Cyft Inc.
• 31.13. Unlearn.AI Inc.
• 31.14. Mendel AI
• 31.15. Deep Lens Inc.

32. Global Artificial Intelligence (AI) In Clinical Trials Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Artificial Intelligence (AI) In Clinical Trials Market

34. Recent Developments In The Artificial Intelligence (AI) In Clinical Trials Market

35. Artificial Intelligence (AI) In Clinical Trials Market High Potential Countries, Segments and Strategies

• 35.1 Artificial Intelligence (AI) In Clinical Trials Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Artificial Intelligence (AI) In Clinical Trials Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Artificial Intelligence (AI) In Clinical Trials Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer